Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Salsalate for Inflammation in PCOS
NCT03229408Phase 2Completed
- Sponsor
- University of Illinois Chicago
- Start
- Dec 2018
- Primary completion
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Amigesic in polycystic ovary syndrome (PCOS), sponsored by University of Illinois Chicago. Started Dec 2018; status: completed.
02
Drugs
Amigesic
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT03229408.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03229408.